Top Markets
Coin of the day
Oriola Oyj Oriola Oyj

Oriola Oyj

OKDAV
Kedudukan dalam Saham #18185
Operating in Sweden, Finland, and internationally, Oriola Oyj is a key provider... Operating in Sweden, Finland, and internationally, Oriola Oyj is a key provider of healthcare and wellbeing products. Their diverse product portfolio includes over-the-counter (OTC) pharmaceuticals, general merchandise, vitamins, dietary supplements, cosmetics, skincare products, sports drinks, and wound care items. Beyond products, Oriola offers essential services such as logistics, advisory support, and comprehensive sales and marketing solutions for pharmaceutical companies, retail and hospital pharmacies, veterinary practices, and grocery retailers. The company also specializes in pharmaceutical staffing and dose dispensing services, catering to both public and private healthcare operators, pharmacies, groceries, veterinarians, and various other retailers. As of December 31, 2021, Oriola managed 319 physical pharmacies in Sweden and maintained a strong online pharmacy presence. Oriola Oyj, which was previously known as Oriola-KD Oyj until its name change in April 2017, is headquartered in Espoo, Finland.
Harga Saham
$1.16
Disegerakkan terakhir: 2025-04-30
Modal Pasaran
$209.58M
Perubahan (1 hari)
-0.57%
Perubahan (1 tahun)
0.00%
Negara
FI
Perdagangan Oriola Oyj (OKDAV)

Kategori

Hasil untuk Oriola Oyj (OKDAV)
Hasil pada Sep 2026 TTM: 0
Menurut laporan kewangan terkini daripada Oriola Oyj, hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Oriola Oyj dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
$410.98B -
US
- -
US
$254.25B -
US
- -
US
$7.64B -
AU